A straightforward chiral pool synthesis for a non-natural calystegin, 3-epi-B 2 , is described. Key steps of this synthesis include an ultrasound-assisted Zn-mediated tandem ring opening reaction followed by a Grubbs' catalyst-mediated ring closure metathesis reaction. Compared to calystegin B 2 , the target compound is no longer an inhibitor for a β -glycosidase hence proving that an equatorial hydroxyl group at position C-3 is necessary for a tight binding of calystegins into the active site of β -glycosidases.
Introduction
Diabetes mellitus type-2 is characterized [1] by high blood glucose levels because of an impaired insulin action. This impaired insulin action ("insulin resistance") is a contributing factor [2 -4] to hypertension, atherosclerosis and a risk factor for coronary heart diseases. Acarbose (Glucobay R , Fig. 1 ) is an antidiabetic drug [5] to treat type-2 diabetes mellitus and prediabetes. It is a glucosidase inhibitor, and it acts by reducing the rate of digestion of complex carbohydrates into monosaccharides.
Calystegins [6] are polyhydroxylated bicyclic nortropane alkaloids which were first isolated from the roots of Calystegia sepium in 1988. They are lead substances [7 -10] for chemotherapeutic drugs for the treatment of diabetes mellitus but also for viral infections, cancer and other metabolic disorders; they have 0932-0776 / 11 / 0300-0317 $ 06.00 c 2011 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com been suggested [11] as pharmacoperones to treat protein folding disorders.
Only a few non-natural calystegins have been synthesized [12, 13] and screened for biological activity so far. Recently, we were able to show that a fluorine substitution at position C-3 in calystegine B 2 ( Fig. 1 ) lowers its affinity to several glucosidases [14] . Based on these findings we became interested in the role of the hydroxyl group at position C-3 and therefore in the synthesis of a 3-epi-calystegin B 2 and the comparison of its activity as an inhibitor of a β -glucosidase.
Results and Discussion
Olefin metathesis is one of the most powerful tools in current organic synthesis. Routes to calystegins using ring closure metatheses [12, 13, 15] as key steps appear most promising and straightforward. Formally, calystegin B 2 is derived from D-glucose; to obtain an analog of inverted configuration at position C-3, a suitable allose derivative can serve as a starting material. Therefore, 1,2 : 5,6-di-O-isopropylidene-α-D-allofuranose 1 [16] was selected as a starting point for our synthesis of 3-epi-calystegin B 2 (11) .
Hydrolysis of 1 with aqueous sulfuric acid (Scheme 1) resulted in the formation of a complex mixture of anomeric pyranoses and furanoses. Treatment of this mixture with methanol in the presence of dry HCl gave a mixture of the corresponding methyl glycosides whose in situ tritylation, benzylation, detritylation and chromatography gave the methyl α-D- 9 Hz is found, the latter being typical for a β -anomeric configuration.
Iodination of 2 using triphenylphosphane, iodine and imidazol [19] gave 6-deoxy-6-iodo-alloside 4 in 78 % yield; iodination of 3 under similar conditions yielded 6 [20] . Ring opening [21, 22] of 4 gave 56 % of the (R)-6-amino-diene 5. The same product could also be obtained from the ring opening of 6 although in a lower yield.
Compound 5 was N-protected by carbobenzoxylation (Scheme 2) to afford 7, which was subjected to a RCM reaction using Grubbs' catalyst (2 nd generation, Cl 2 Ru(Imes)[P(cyclohexyl) 3 ]=CHPh) [21, 22] , and the cycloheptene 8 was obtained. Regioselective oxidation of 8 using the borane-THF complex followed by oxidative work-up [23] and PCC oxidation of 9 gave the cycloheptanone 10. Compound 10 is characterized in its IR spectrum by a strong adsorption at ν = 1694 cm −1 for the carbonyl group of the ketone; this carbonyl group is also detected by a 13 C NMR signal at δ = 208.0 ppm. Hydrogenation of 10 with Pd/C (10 %) in ethyl acetate/acetic acid finally gave the target compound 11.
Compared with naturally occurring calystegin B 2 , the signal of C-3 in 3-epi-B 2 is shifted to δ = 66.9 ppm (|∆δ | = 8.3 ppm, cf. C-3 in calystegin B2 δ = 75.2 ppm), and that of 3-H is shifted to δ = 3.67 ppm (|∆δ | = 0.43; cf. 3-H in calystegin B2 δ = 3.24 ppm). A proof for the D-allo-configuration is found in the coupling constants 3 J 2-H,3-H = 3.9 Hz (for calystegin B 2 J = 8.5 Hz was detected) and 3 J 3-H,4-H = 4.2 Hz.
Calystegin B 2 is a competitive inhibitor for the β -glucosidase from almonds. In a 4-nitro-phenolate as-say [24] a K i = 5.9 µ M was determined. A previously prepared 3-fluoro analog [14] gave a K i = 82 µ M. For compound 11, however, no inhibition of the enzyme could be measured even at an inhibitor concentration of 10 mM. This might be explained by the axial position of the hydroxyl group at position C-3, therefore proving that an equatorial hydroxyl group at this position is necessary for a tight binding of the inhibitor into the active site of β -glycosidases.
Experimental Section

General methods
Melting points are uncorrected (Leica hot stage microscope). Optical rotations were obtained using a Perkin-Elmer 341 polarimeter (1 cm micro cell, 20 • C). NMR spectra were recorded using the Varian spectrometers Gemini 200, Gemini 2000 or Unity 500 (δ given in ppm, J in Hz, internal SiMe 4 or internal CCl 3 F), IR spectra (film or KBr pellet) on a Perkin-Elmer FT-IR spectrometer Spectrum 1000. Mass spectra were taken on a Thermo Electron Finnigan LCQ instrument (electrospray, voltage 4.5 kV, sheath gas nitrogen). For elemental analysis, a Foss-Heraeus Vario EL instrument was used. TLC was performed on silica gel (Merck 5554, detection by UV absorption or by treatment with a solution of 10 % sulfuric acid, ammonium molybdate and cerium(IV) sulfate, followed by gentle heating). The solvents were dried according to usual procedures.
Methyl 2,3,4-tri-O-benzyl-α-D-allopyranoside (2) and methyl 2,3,4-tri-O-benzyl-β -D-allopyranoside (3)
A suspension of 1 (6.0 g, 23.1 mmol) in water (50 mL) and conc. sulfuric acid (98 %, 1 mL) was stirred at 25 • C for 24 h. The mixture was neutralized by the addition of NaHCO 3 (3.0 g), the solvents were removed and the residue was suspended in dry methanol (50 mL), the mixture was filtered and the filtrate was evaporated. The residue was dissolved in dry methanol (50 mL), and a 0 • C cold solution of methanol (5 mL) containing acetyl chloride (0.5 mL) was added. The mixture was heated under reflux for 8 h, neutralized (NaHCO 3 ), filtered and the solvents were removed from the filtrate. The residue was dissolved in dry pyridine (50 mL), trityl chloride (9.63 g, 34.6 mmol) and DMAP (0.4 g, 3.3 mmol) were added and stirring at 25 • C was continued for another 16 h. The solvent was removed, the residue re-dissolved in ether (100 mL), the solution was extracted with water (100 mL), the organic phase was dried (Na 2 SO 4 ) and the solvents were removed. Purification by chromatography (silica gel, methanol/ethyl acetate 5 : 95) gave a mixture of the corresponding pyranosides [(56 g, 12.8 mmol; α: R f = 0.35 (in ethyl acetate), β : R f = 0.49 (in ethyl acetate)]. The mixture of the pyranosides (5.6 g, 12.8 mmol) was dissolved in dry DMF (100 mL), and at 0 • C NaH (55 % in mineral oil, 2.79 g, 64 mmol) was added, stirring at 25 • C continued for 15 min, and benzyl bromide (9.84 g, 57.6 mmol) was added. After stirring for 5 h at 25 • C, methanol (30 mL) was slowly added to quench the reaction, and the solvents were removed under reduced pressure. The residue was redissolved in diethyl ether (150 mL), the solution washed with water (3×25 mL) and brine (2×25 mL) and dried (Na 2 SO 4 ), and the solvents were removed. The residue was dissolved in a mixture of dichloromethane/methanol (100 mL, 2 : 1) containing catalytic amounts of p-toluenesulfonic acid and the solution stirred for 12 h at 25 • C. After neutralization with Nmethylmorpholine and a usual aqueous work-up, the residue was purified by chromatography (silica gel, hexane/ethyl ac- 
Methyl 2,3,4-tri-O-benzyl-6-deoxy-6-iodo-α-D-allopyranoside (4)
As described below for 6, from 2 (1.02 g, 2. 
(3 R, 4 R, 5 S, 6 R)-6-[(N-Benzyl)amino]-3,4,5-tris-(benzyloxy)-l,8-nonadiene (5)
A suspension of 6 (1.52 g, 2.65 mmol) and activated zinc powder (1.73 g, 26.5 mmol) in abs. THF (50 mL) was heated in an ultrasound bath at 40 • C, and within 30 min benzylamine (0.71 g, 6.62 mmol) was added. Sonification at 40 • C was continued for another 3 h. Allyl bromide (0.75 g, 6.62 g) was added and sonification continued for 4 h. The mixture was filtered through a small layer of silica gel, the silica gel was washed with ethyl acetate (500 mL), the solvents were removed, and the residue was subjected to chromatography (silica gel, hexane/ethyl acetate 85 : 15) to afford 5 (350 mg, 49.2 %) as a colorless oil. In an analogous manner, compound 5 (56.5 %) was obtained from 4 as a colorless oil. ν = 3064m, 3030m, 2865m,  1699m, 1496s, 1454s, 1331w, 1208m, 1100s, 1070s, 1028s,  997m, 735s, 697s 
Methyl 2,3,4-tri-O-benzyl-6-deoxy-6-iodo-β -D-allopyranoside (6)
To a solution of 3 (2.66 g, 5.7 mmol), triphenylphosphane (3.3 g, 12.54 mmol) and imidazole (1.75 g, 25.65 mmol) in dry toluene (50 mL), iodine (2.91 g, 11.46 mmol) was added in several portions at 95 • C. Stirring was continued for 2 h, the hot solvent was decanted and the viscous residue rinsed with diethyl ether (3 × 25 mL). Purification of the residue by chromatography (silica gel, hexane/ethyl acetate 85 : 15) yielded 6 (2. 
(3 R, 4 R, 5 S, 6 R) 6-[(N-BenzyI-N-(benzyloxycarbonyl))-amino]-3,4,5-tris(benzyloxy)-l,8-nonadiene (7)
To a solution of 5 (819 mg, 1.50 mmol) in dichloromethane/water (5 : 1, 50 mL), NaHCO 3 (1.26 g, 15.0 mmol) and benzyl chloroformate (766 mg, 4.5 mmol) in ethyl acetate (10 mL) were added. After stirring for 2 h at r. t., the phases were separated, the aqueous phase extracted with dichloromethane (3 × 25 mL). The organic phases were combined and the solvents removed. The residue was subjected to chromatography (silica gel, hexane/ethyl acetate 85 : 15) to yield 7 (890 mg, 87.0 %) as a colorless oil. 
